Regulatory and data changes can incentivise innovation in life sciences
A continuation of regulatory flexibilities deployed during the coronavirus crisis and the introduction of clear guidelines on the use of patient data in health research initiatives can help incentivise innovation in life sciences, legal experts have said.
